Seven Eight Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-67,885
Closed -$2.12M 810
2023
Q4
$2.12M Buy
67,885
+21,718
+47% +$780K 0.25% 112
2023
Q3
$1.85M Buy
46,167
+36,327
+369% +$1.7M 0.22% 120
2023
Q2
$517K Buy
+9,840
New +$599K 0.09% 307
2023
Q1
Sell
-12,458
Closed -$605K 601
2022
Q4
$605K Buy
+12,458
New +$781K 0.16% 191
2021
Q4
Sell
-2,585
Closed -$332K 663
2021
Q3
$332K Sell
2,585
-2,500
-49% -$350K 0.03% 489
2021
Q2
$775K Buy
+5,085
New +$670K 0.11% 324
2018
Q4
Sell
-19,900
Closed -$955K 700
2018
Q3
$955K Buy
+19,900
New +$815K 0.06% 368

Other funds holding STAA

Seven Eight Capital's STAA Position: Q1 2024 in Review

Seven Eight Capital sold out of STAAR Surgical (STAA) in Q1 2024, closing a stake of 67,885 shares — an estimated $2.12M sold.

Seven Eight Capital first reported a position in STAA in Q3 2018 and held it in 7 quarters. The position peaked at $2.12M in Q4 2023. 198 funds tracked by Wall St. Rank hold STAA as of Q1 2024.

  • Seven Eight Capital reported no remaining STAAR Surgical position as of Q1 2024 after selling out during the quarter.
  • Seven Eight Capital sold 67,885 STAAR Surgical shares in Q1 2024, an estimated $2.12M.
  • Seven Eight Capital first reported a position in STAAR Surgical in Q3 2018 and held it in 7 quarters.
  • Seven Eight Capital's STAAR Surgical position peaked at $2.12M in Q4 2023.
  • 198 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.